BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 180414)

  • 1. Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice.
    Baron S; Worthington MG; Williams J; Gaines JW
    Nature; 1976 Jun; 261(5560):505-6. PubMed ID: 180414
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection.
    Starr SE; Visintine AM; Tomeh MO; Nahmias AJ
    Proc Soc Exp Biol Med; 1976 May; 152(1):57-60. PubMed ID: 177992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy and drugs in neonatal disseminated herpes simplex virus type 2 infections: a mouse model.
    Strulovitch C; Marks MI; Soneji A; Goldberg S
    J Antimicrob Chemother; 1979 Jul; 5(4):437-46. PubMed ID: 226512
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
    Kohl S; Loo LS; Greenberg SB
    J Immunol; 1982 Mar; 128(3):1107-11. PubMed ID: 6173420
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of interleukin-2 and macrophages to treat herpes simplex virus infection in neonatal mice.
    Kohl S; Loo LS
    J Infect Dis; 1988 Jun; 157(6):1187-92. PubMed ID: 2836520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus vaccines.
    Wise TG; Pavan PR; Ennis FA
    J Infect Dis; 1977 Nov; 136(5):706-11. PubMed ID: 199677
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of herpes simplex virus immunity in newborn mice.
    Koyama H; Kasahara S
    Infect Immun; 1975 Dec; 12(6):1472-4. PubMed ID: 173657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective production of anti-herpes simplex virus antibody by neonatal mice. Reconstitution with Ia+ macrophages and T helper lymphocytes from nonimmune adult syngeneic mice.
    Kohl S; Thomas JW; Loo LS
    J Immunol; 1986 Apr; 136(8):3038-44. PubMed ID: 3007609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity in vivo.
    Voss LM; David CS; Showalter SD; Paya CV; Leibson PJ
    Int Immunol; 1992 Mar; 4(3):417-20. PubMed ID: 1314641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal herpes simplex virus infection: relapse after initial therapy and transmission from a mother with an asymptomatic genital herpes infection and erythema multiforme.
    Brown ZA; Ashley R; Douglas J; Keilly M; Corey L
    Pediatr Infect Dis J; 1987 Nov; 6(11):1057-61. PubMed ID: 2827097
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of antibody in the treatment of acute herpes simplex virus disease and in the pathogenesis of latency in newborn guinea pigs.
    Tenser RB
    J Infect Dis; 1996 Sep; 174(3):667-8. PubMed ID: 8769635
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of adenine arabinoside and host defense factors in experimental infections due to Herpesvirus hominis.
    Cho CT; Feng KK
    J Infect Dis; 1977 Mar; 135(3):468-72. PubMed ID: 191543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different mechanisms of protection by monoclonal and polyclonal antibodies during the course of herpes simplex virus infection.
    Eis-Hübinger AM; Mohr K; Schneweis KE
    Intervirology; 1991; 32(6):351-60. PubMed ID: 1657825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus type 2 infection of neonatal mice.
    Baker DA; Plotkin SA
    Infection; 1978; 6(4):158-61. PubMed ID: 211091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with herpes simplex virus.
    Pack CD; Kumaraguru U; Suvas S; Rouse BT
    Vaccine; 2005 May; 23(27):3526-34. PubMed ID: 15855011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of recurrent herpes simplex].
    Eichmann A
    Z Hautkr; 1977 Apr; 52(8):475-82. PubMed ID: 194427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylaxis and treatment of alpha herpesvirus infection--vaccine].
    Kimura H
    Nihon Rinsho; 2000 Apr; 58(4):928-32. PubMed ID: 10774218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes.
    Rouse DJ; Stringer JS
    Am J Obstet Gynecol; 2000 Aug; 183(2):400-6. PubMed ID: 10942477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy with inactivated polyvalent herpes vaccines.
    Dundarov S; Andonov P; Bakalov B; Nechev K; Tomov C
    Dev Biol Stand; 1982; 52():351-8. PubMed ID: 6299844
    [No Abstract]   [Full Text] [Related]  

  • 20. Herpes simplex virus specific antibody determined by immunoblotting in cerebrospinal fluid of a patient with the Guillain-Barré syndrome.
    Bernsen HJ; Van Loon AM; Poels RF; Verhagen WI; Frenken CW
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):788-91. PubMed ID: 2545828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.